Celdara Medical Enters Into CRADA with USAMRIID and the Geneva Foundation to Evaluate the Efficacy of CM-JLD, an Antibody Cocktail for Sudan Virus
Celdara Medical, a clinical-stage biotechnology company focused on delivering products to patients, announced today that it has entered into a Cooperative Research and Development Agreement (CRADA) with the United States Army Medical Research Institute of Infectious Diseases (USAMRIID) and The Geneva Foundation, 501(c)3 non-profit organization that advances military medical research. This collaboration is focused on the development of a therapeutic antibody cocktail candidate for the treatment of Sudan virus, using established animal models to test efficacy against viral infection. There...
View full press release